Case Report
Burkholderia cepacia Sepsis in a Previously Healthy Full-Term Infant
Table 2
Sputum culture susceptibilities.
| | A | B | C | D | E |
| | Enterobacter cloacae complex | | | MIC dilutn | MIC interp | — | — | | Cefepime | 8 | L | — | — | | Cafoxitin | ≥64 | R | — | — | | Ceftazidime | ≥64 | R | — | — | | Ceftriaxone | ≥64 | R | — | — | | Ciprofloxacin | ≤0.25 | S | — | — | | Gentamicin | ≤1 | S | — | — | | Levofloxacin | ≤0.12 | S | — | — | | Meropenem | 1 | S | — | — | | Piperacillin/tazobactam | ≥128 | R | — | — | | Tetracycline | 4 | S | — | — | | Trimethoprim/sulfa | ≤20 | S | — | — |
| | Stenotrophomonas maltophilia | | | Generic interpretation | Generic interpretation numeric | MIC dilutn | MIC interp | | Ceftazidime Etest | S | 1 | — | — | | Levofloxacin | — | — | ≤0.12 | S | | Minocycline Etest | S | 1 | — | — | | Trimethoprim/sulfa | — | — | ≤20 | S |
| | Burkholderia cepacia complex | | | MIC dilutn | MIC interp | — | — | | Amikacin | ≥64 | R | — | — | | Cefepime | ≤1 | S | — | — | | Ceftazidime | 2 | S | — | — | | Gentamicin | ≥16 | R | — | — | | Levofloxacin | 1 | S | — | — | | Meropenem | ≥16 | R | — | — | | Piperacillin/tazobactam | ≥128 | R | — | — | | Tetracycline | 4 | S | — | — | | Tobramycin | ≥16 | R | — | — | | Trimethoprim/sulfa | ≤20 | S | — | — |
|
|
